Immunohistochemical detection of gastrin releasing peptide in patients with prostate cancer
- 1 August 2003
- journal article
- research article
- Published by Springer Nature in World Journal of Urology
- Vol. 21 (3) , 183-187
Abstract
Gastrin releasing peptide (GRP) is a neuropeptide that has been suggested to play a role in the development of some malignancies. Our aim was: (1) to identify the expression of GRP in cancerous prostate glands, and (2) to correlate its expression to various pathological parameters and to the patient's clinical outcome. Using standard immunohistochemistry, we evaluated GRP expression in both biopsy and radical prostatectomy specimens from 30 patients with prostatic adenocarcinomas. GRP was expressed in 18 radical prostatectomy specimens (60%) and in 15 biopsies (50%). There was an association between positive immunoexpression of GRP, relapse (P=0.029) and advanced tumor stages (i.e. pT3, pT4) (P=0.049). In the respective biopsies, GRP immunostatus was similar to that observed in the subsequent radical prostatectomy specimens. GRP immunoexpression may be of some value as a diagnostic and prognostic marker. Patients whose pathology specimens demonstrate GRP immunopositivity should be closely monitored, since they appear to be at higher risk of disease progression and relapse.Keywords
This publication has 16 references indexed in Scilit:
- Effect of prostatic neuropeptides on migration of prostate cancer cell linesInternational Journal of Urology, 2001
- Peptide analogs in the therapy of prostate cancerThe Prostate, 2000
- Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancersThe Prostate, 2000
- Androgen-independent growth is induced by neuropeptides in human prostate cancer cell linesThe Prostate, 1999
- Future prospects in prostate cancerThe Prostate, 1999
- Effect of prostatic neuropeptides on invasion and migration of PC-3 prostate cancer cellsCancer Letters, 1998
- Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cellsThe Prostate, 1997
- Characterization of high‐affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC‐3 and DU‐145: Internalization of receptor bound 125I‐(Tyr4) bombesin by tumor cellsThe Prostate, 1994
- Differential Effects of Peptide Hormones Bombesin, Vasoactive Intestinal Polypeptide and Somatostatin Analog RC-160 on the Invasive Capacity of Human Prostatic Carcinoma CellsJournal of Urology, 1993
- Bombesin stimulates growth of human prostatic cancer cellsin vitroCancer, 1990